A Study Using Botulinum Toxin Type A in Adolescents With Axillary Hyperhidrosis

A study using Botulinum Toxin Type A in adolescents with axillary hyperhidrosis.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hyperhidrosis Skin Diseases Skin and Connective Tissue Diseases Sweat Gland Diseases

Age range

12 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Vancouver, British Columbia, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Marked axillary hyperhidrosis

Exclusion criteria

Previous use of botulinum toxin for hyperhidrosis

Treatment and study plan

Botulinum toxin type A

Biological

100 U up to 6 times during the study depending on the response to treatment

Other names: BOTOX®

Primary outcomes

Subject's assessment of the severity of hyperhidrosis using the HDS Scale

Time frame: Monthly

Secondary outcomes

Measurement of axillary sweat production

Time frame: Week 4, Week 8 and any re-injection visit

Sponsors and collaborators

Lead sponsor

Allergan

Industry

Registry information

Important dates

Study start: 2005
Primary completion: 2007
Study completion: 2007
First posted: Sep 15, 2005
Registry last updated: Sep 29, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed